The UK market recently faced challenges, with the FTSE 100 index closing lower due to weak trade data from China, highlighting the interconnected nature of global economies. Amidst these broader market fluctuations, investors often seek opportunities in lesser-known areas such as penny stocks. Though considered a niche investment area today, penny stocks can offer potential growth when backed by strong financials and solid fundamentals.
Top 10 Penny Stocks In The United Kingdom
| Name |
Share Price |
Market Cap |
Financial Health Rating |
| BRCK Group (AIM:BRCK) |
£0.535 |
£172.45M |
★★★★★☆ |
| Foresight Group Holdings (LSE:FSG) |
£4.02 |
£453.9M |
★★★★★★ |
| Keystone Law Group (AIM:KEYS) |
£4.775 |
£151.45M |
★★★★★★ |
| Hollywood Bowl Group (LSE:BOWL) |
£2.62 |
£439.2M |
★★★★☆☆ |
| Ingenta (AIM:ING) |
£1.14 |
£17.21M |
★★★★★★ |
| Integrated Diagnostics Holdings (LSE:IDHC) |
$0.622 |
$361.58M |
★★★★★☆ |
| Gulf Keystone Petroleum (LSE:GKP) |
£1.85 |
£402.27M |
★★★★★★ |
| BTG Consulting (AIM:BTG) |
£1.19 |
£191.84M |
★★★★★☆ |
| Billington Holdings (AIM:BILN) |
£4.05 |
£52.87M |
★★★★★★ |
| Norman Broadbent (AIM:NBB) |
£2.23 |
£4.1M |
★★★★★★ |
Click here to see the full list of 276 stocks from our UK Penny Stocks screener.
Here we highlight a subset of our preferred stocks from the screener.
IDOX
Simply Wall St Financial Health Rating:★★★★★☆
Overview:IDOX plc, with a market cap of £326.24 million, offers software and services for managing local government and other organizations across the UK, US, Europe, and internationally.
Operations:The company's revenue is derived from three segments: Assets (£15.60 million), Communities (£16.95 million), and Land Property & Public Protection (£57.28 million).
Market Cap:£326.24M
IDOX plc, with a market cap of £326.24 million, demonstrates solid financial health and growth potential as a penny stock. The company's earnings have grown by 17.1% over the past year, surpassing the software industry's average growth rate. Despite a low return on equity of 7.4%, IDOX's debt management is commendable, with its net debt to equity ratio at a satisfactory 16%. Its short-term assets slightly fall short in covering liabilities but comfortably exceed long-term obligations. Recent earnings reports show increased sales and net income compared to the previous year, highlighting consistent performance improvement.
-
Get an in-depth perspective on IDOX's performance by reading our balance sheet health report here.
-
Review our growth performance report to gain insights into IDOX's future.
Mha
Simply Wall St Financial Health Rating:★★★★★☆
Overview:Mha Plc provides financial and business strategy services to enterprises and individuals, with a market cap of £336.71 million.
Operations:The company generates revenue from the provision of professional services amounting to £238.26 million.
Market Cap:£336.71M
MHA Plc, with a market cap of £336.71 million, exhibits strong financial metrics despite recent challenges. The company maintains more cash than its total debt and covers interest payments well with EBIT. However, profit margins have decreased from 36.9% to 23.8%, and earnings are forecasted to decline by an average of 23.7% annually over the next three years. MHA's price-to-earnings ratio is favorable at 5.9x compared to the UK market average of 16.2x, suggesting good value relative to peers despite negative earnings growth last year (-18.6%). Recent management changes aim to bolster strategic capabilities in banking and tax services.
-
Unlock comprehensive insights into our analysis of Mha stock in this financial health report.
-
Understand Mha's earnings outlook by examining our growth report.
TPXimpact Holdings
Simply Wall St Financial Health Rating:★★★★★★
Overview:TPXimpact Holdings plc, along with its subsidiaries, offers digital native technology services across the United Kingdom, Switzerland, and internationally, with a market capitalization of £34.60 million.
Operations:The company has not reported any specific revenue segments.
Market Cap:£34.6M
TPXimpact Holdings, with a market cap of £34.60 million, has been actively securing significant contracts despite its unprofitability and negative return on equity (-18.91%). Recent strategic wins include a EUR 39 million contract with DEFRA and a £22 million award from NHS England, enhancing its digital transformation footprint. The company maintains a satisfactory net debt to equity ratio (6.1%) and possesses sufficient cash runway for over three years due to positive free cash flow growth. However, TPX's share price remains highly volatile, trading at 77.1% below estimated fair value amidst efforts to drive future growth through new leadership appointments.
-
Dive into the specifics of TPXimpact Holdings here with our thorough balance sheet health report.
-
Gain insights into TPXimpact Holdings' future direction by reviewing our growth report.
Key Takeaways
-
Reveal the 276 hidden gems among our UK Penny Stocks screener with a single click here.
-
Interested In Other Possibilities? AI is about to change healthcare. These 127 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AIM:IDOX AIM:MHA and AIM:TPX.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
